Endoluminal stents are commonly used for palliative treatment of dysphagia in patients with advanced esophageal malignancies. The most frequently used esophageal stents are self-expanding metal stents. Removable self-expanding plastic stents have recently been used in the management of esophageal cancer patients treated with curative intent. Esophageal stents effectively alleviate dysphagia in most patients, and stent placement is associated with a low rate of complications. This article reviews the use of self-expanding esophageal stents in patients with esophageal cancer. Nutrition considerations following stent placement are addressed.
HashemiNLorenDDiMarinoAJCohenS. Presentation and prognosis of esophageal adenocarcinoma in patients below age 50. Dig Dis Sci. 2009;54:1708-1712.
2.
BozzettiF. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer. 2009;17:279-284.
3.
Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society; 2009.
4.
RaJPaulsonECKucharczukJ. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol. 2008;15:1577-1584.
5.
KohnGPGalankoJAMeyersMOFeinsRHFarrellTM. National trends in esophageal surgery-are outcomes as good as we believe?J Gastrointest Surg. 2009;13:1900-1910.
6.
HerskovicAMartzKal-SarrafM. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
7.
MinskyBDPajakTFGinsbergRJ. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167-1174.
8.
O’DonnellCAFullartonGMWattELennonKMurrayGDMossJG. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg. 2002;89:985-992.
9.
UrschelJDCockburnJSFooteAV. Palliation of oesophageal cancer—endoscopic intubation and laser therapy. Postgrad Med J. 1991;67:414-416.
10.
VakilNMorrisAIMarconN. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 2001;96:1791-1796.
11.
MayoralWFleischerDSalcedoJRoyPAl-KawasFBenjaminS. Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc. 2000;51:556-559.
12.
ElphickDASmithBABagshawJRileySA. Self-expanding metal stents in the palliation of malignant dysphagia: outcome analysis in 100 consecutive patients. Dis Esophagus. 2005;18:93-95.
13.
WengerUJohnssonEArneloULundellLLagergrenJ. An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study. Surg Endosc. 2006;20:1675-1680.
14.
ShimCSJungISCheonYK. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antireflux mechanism. Endoscopy. 2005;37:335-339.
15.
LaaschHUMarriottAWilbrahamLTunnahSEnglandREMartinDF. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology. 2002;225:359-365.
16.
KnyrimKWagnerHJBethgeNKeymlingMVakilN. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med. 1993;329:1302-1307.
17.
MadhusudhanCSalujaSSPalS. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus. 2009;22:331-336.
18.
ConioMRepiciABattagliaG. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007;102:2667-2677.
19.
SiersemaPDHopWCvan BlankensteinM. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001;54:145-153.
20.
SelingerCPEllulPSmithPAColeNC. Oesophageal stent insertion for palliation of dysphagia in a district general hospital: experience from a case series of 137 patients. QJM. 2008;101:545-548.
21.
HomsMYSteyerbergEWKuipersEJ. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy. 2004;36:880-886.
22.
KoHKSongHYShinJHLeeGHJungHYParkSI. Fate of migrated esophageal and gastroduodenal stents: experience in 70 patients. J Vasc Interv Radiol. 2007;18:725-732.
23.
SzegediLGalIKosaIKissGG. Palliative treatment of esophageal carcinoma with self-expanding plastic stents: a report on 69 cases. Eur J Gastroenterol Hepatol. 2006;18:1197-1201.
24.
SiersemaPDSchrauwenSLvan BlankensteinM. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc. 2001;54:579-586.
25.
BowerMJonesWVesselsBScogginsCMartinR. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy. Ann Surg Oncol. 2009;16:3161-3168.
26.
DallalHJSmithGDGrieveDCGhoshSPenmanIDPalmerKR. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc. 2001;54:549-557.
27.
HomsMYSteyerbergEWEijkenboomWM. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364:1497-1504.
28.
SteyerbergEWHomsMYStokvisAEssink-BotMLSiersemaPD. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc. 2005;62:333-340.
29.
ShenfineJMcNameePSteenNBondJGriffinSM. A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol. 2009;104:1674-1685.
30.
MoscaFConsoliAStracqualursiAPersiAPortaleTR. Comparative retrospective study on the use of plastic prostheses and self-expanding metal stents in the palliative treatment of malignant strictures of the esophagus and cardia. Dis Esophagus. 2003;16:119-125.
31.
BozzettiFCozzaglioLGavazziC. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori. 1998;84:681-686.
32.
KoeaJBShawJH. The effect of tumor bulk on the metabolic response to cancer. Ann Surg. 1992;215:282-288.
33.
SaitoTKuwaharaAShigemitsuY. Factors related to malnutrition in patients with esophageal cancer. Nutrition. 1991;7:117-121.
34.
SiddiquiAAGlynnCLorenDKowalskiT. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study. Dis Esophagus. 2009;22:216-222.
35.
DetskyASMcLaughlinJRBakerJP. What is subjective global assessment of nutritional status?JPEN J Parenter Enteral Nutr. 1987;11:8-13.
36.
PaccagnellaAMorelloMDa MostoMC. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy [published online ahead of print August 30, 2009]. Support Care Cancer.
37.
DalyJMWeintraubFNShouJRosatoEFLuciaM. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995;221:327-338.
38.
Marin CaroMLavianoAPichardC. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007;26:289-301.
39.
RavascoPMonteiro-GrilloIVidalPMCamiloME. Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer. 2004;12:246-252.
40.
LecleireSDi FioreFAntoniettiM. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc. 2006;64:479-484.
41.
McCannRMHallWJGroth-JunckerA. Comfort care for terminally ill patients: the appropriate use of nutrition and hydration. JAMA. 1994;272:1263-1266.
42.
BachmannPMarti-MassoudCBlanc-VincentMP. Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001). Br J Cancer. 2003;89(suppl 1):S107-S110.
43.
RavascoPMonteiro GrilloICamiloM. Cancer wasting and quality of life react to early individualized nutritional counselling!Clin Nutr. 2007;26:7-15.
44.
ColomerRMoreno-NogueiraJMGarcia-LunaPP. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007;97:823-831.
45.
ReadJABealePJVolkerDHSmithNChildsAClarkeSJ. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer: effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer. 2007;15:301-307.
46.
BarberMDRossJAVossACTisdaleMJFearonKC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999;81:80-86.
47.
OdelliCBurgessDBatemanL. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol (R Coll Radiol). 2005;17:639-645.
48.
ConigliaroRBattagliaGRepiciA. Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol. 2007;19:195-203.
49.
SiddiquiAALorenDDudnickRKowalskiT. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci. 2007;52:823-829.
50.
OttCRatiuNEndlicherE. Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes. Surg Endosc. 2007;21:889-896.
